XML 46 R3.htm IDEA: XBRL DOCUMENT
v3.25.1

Award Timing Disclosure | 12 Months Ended |  |
--- | --- | --- | ---
Dec. 31, 2024 | May 13, 2024 USD ($) share $ / shares | Jan. 04, 2024 USD ($) share $ / shares
Award Timing Disclosures [Line Items] |  |  |
Award Timing MNPI Disclosure | We do not have any program, plan, or obligation that requires us to grant equity awards on specified dates, although the Company’s long-standing practice has been to make annual equity grants in January and May of each year at the regularly scheduled meetings of our Compensation Committee and Board. We believe this allows management, the Compensation Committee and the Board to conduct a fulsome review of all elements of compensation on a consistent basis each year. The Board, with respect to our CEO, and the Compensation Committee, with respect to our remaining NEOs, may also grant equity awards from time to time in recognition of a NEO’s expanded duties and responsibilities or continuing contributions to the Company’s performance. Neither the Compensation Committee nor the Board takes material nonpublic information into account when determining the timing and terms of grants of equity compensation. Further, we do not have any program, plan or practice to time grant dates of equity compensation awards in coordination with the release of material nonpublic information and have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. Pursuant to Item 402(x) of Regulation S-K under the Exchange Act, we are providing the following information regarding awards granted to named executive officers of the Company on the following dates: •January 4, 2024, which was one business day before the filing of a Current Report on Form 8-K with which the Company furnished a slide presentation to be used by management at the 42 nd Annual J.P. Morgan Healthcare Conference; and •May 13, 2024, which was the date of the filing of a Current Report on Form 8-K in which the Company reported the results of the 2024 Annual Meeting.
|  |  | Grant date |  | Number of securities underlying the award |  | Per share exercise price of the award ($) |  | Grant date fair value of the award ($) |  | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (%) |
| William H. Lewis |  | 01/04/2024 |  | 186,970 |  | 29.13 |  | 3,309,762 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 209,320 |  | 25.83 |  | 3,308,972 |  |  | (2.00) |  |
| Sara Bonstein |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
| Roger Adsett |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
| Martina Flammer, M.D. |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
| Drayton Wise |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
Award Timing Method | Neither the Compensation Committee nor the Board takes material nonpublic information into account when determining the timing and terms of grants of equity compensation. Further, we do not have any program, plan or practice to time grant dates of equity compensation awards in coordination with the release of material nonpublic information and have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. |  |
Award Timing Predetermined | true |  |
Award Timing MNPI Considered | true |  |
Award Timing, How MNPI Considered | We do not have any program, plan, or obligation that requires us to grant equity awards on specified dates, although the Company’s long-standing practice has been to make annual equity grants in January and May of each year at the regularly scheduled meetings of our Compensation Committee and Board. We believe this allows management, the Compensation Committee and the Board to conduct a fulsome review of all elements of compensation on a consistent basis each year. The Board, with respect to our CEO, and the Compensation Committee, with respect to our remaining NEOs, may also grant equity awards from time to time in recognition of a NEO’s expanded duties and responsibilities or continuing contributions to the Company’s performance. Neither the Compensation Committee nor the Board takes material nonpublic information into account when determining the timing and terms of grants of equity compensation. Further, we do not have any program, plan or practice to time grant dates of equity compensation awards in coordination with the release of material nonpublic information and have not timed the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. |  |
MNPI Disclosure Timed for Compensation Value | false |  |
Awards Close in Time to MNPI Disclosures, Table |
|  |  | Grant date |  | Number of securities underlying the award |  | Per share exercise price of the award ($) |  | Grant date fair value of the award ($) |  | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (%) |
| William H. Lewis |  | 01/04/2024 |  | 186,970 |  | 29.13 |  | 3,309,762 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 209,320 |  | 25.83 |  | 3,308,972 |  |  | (2.00) |  |
| Sara Bonstein |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
| Roger Adsett |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
| Martina Flammer, M.D. |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
| Drayton Wise |  | 01/04/2024 |  | 63,560 |  | 29.13 |  | 1,125,145 |  |  | 2.75 |  |
|  | 05/13/2024 |  | 71,160 |  | 25.83 |  | 1,124,912 |  |  | (2.00) |  |
William H. Lewis [Member] |  |  |
Awards Close in Time to MNPI Disclosures |  |  |
Name |  | William H. Lewis | William H. Lewis
Underlying Securities | share |  | 209,320 | 186,970
Exercise Price | $ / shares |  | $ 25.83 | $ 29.13
Fair Value as of Grant Date | $ |  | $ 3,308,972 | $ 3,309,762
Underlying Security Market Price Change |  | (0.0200) | 0.0275
Sara Bonstein [Member] |  |  |
Awards Close in Time to MNPI Disclosures |  |  |
Name |  | Sara Bonstein | Sara Bonstein
Underlying Securities | share |  | 71,160 | 63,560
Exercise Price | $ / shares |  | $ 25.83 | $ 29.13
Fair Value as of Grant Date | $ |  | $ 1,124,912 | $ 1,125,145
Underlying Security Market Price Change |  | (0.0200) | 0.0275
Roger Adsett [Member] |  |  |
Awards Close in Time to MNPI Disclosures |  |  |
Name |  | oger Adsett | oger Adsett
Underlying Securities | share |  | 71,160 | 63,560
Exercise Price | $ / shares |  | $ 25.83 | $ 29.13
Fair Value as of Grant Date | $ |  | $ 1,124,912 | $ 1,125,145
Underlying Security Market Price Change |  | (0.0200) | 0.0275
Martina Flammer, M.D. [Member] |  |  |
Awards Close in Time to MNPI Disclosures |  |  |
Name |  | Martina Flammer, M.D. | Martina Flammer, M.D.
Underlying Securities | share |  | 71,160 | 63,560
Exercise Price | $ / shares |  | $ 25.83 | $ 29.13
Fair Value as of Grant Date | $ |  | $ 1,124,912 | $ 1,125,145
Underlying Security Market Price Change |  | (0.0200) | 0.0275
Drayton Wise [Member] |  |  |
Awards Close in Time to MNPI Disclosures |  |  |
Name |  | Drayton Wise | Drayton Wise
Underlying Securities | share |  | 71,160 | 63,560
Exercise Price | $ / shares |  | $ 25.83 | $ 29.13
Fair Value as of Grant Date | $ |  | $ 1,124,912 | $ 1,125,145
Underlying Security Market Price Change |  | (0.0200) | 0.0275

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence D + Details
Name: | ecd_AwardExrcPrice
Namespace Prefix: | ecd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence E + Details
Name: | ecd_AwardGrantDateFairValue
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgDiscLineItems
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgHowMnpiCnsdrdTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMethodTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiCnsdrdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiDiscTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgPredtrmndFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence C + Details
Name: | ecd_AwardUndrlygSecuritiesAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence A + Details
Name: | ecd_AwardsCloseToMnpiDiscIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_MnpiDiscTimedForCompValFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence F + Details
Name: | ecd_UndrlygSecurityMktPriceChngPct
Namespace Prefix: | ecd_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=insm_WilliamH.LewisMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=insm_SaraBonsteinMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=insm_RogerAdsettMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=insm_MartinaFlammerM.D.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=insm_DraytonWiseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |